DexCom, Inc. ( DXCM) - Key Metrics
DXCM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.41 | $0.65 | $0.70 | $0.48 |
| 2026Q1 | $3.10 | $0.52 | $1.36 | $1.17 |
| 2025Q4 | $3.26 | $0.69 | $0.76 | $0.50 |
| 2025Q3 | $3.09 | $0.73 | $1.69 | $1.48 |
| 2025Q2 | $2.95 | $0.46 | $0.77 | $0.53 |
DXCM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 25.90 |
| 2026Q1 | 0% | 30.19 |
| 2025Q4 | 0% | 24.05 |
| 2025Q3 | 0% | 23.04 |
| 2025Q2 | 0% | 47.44 |
DXCM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.71% | 0% |
| 2026Q1 | 1.86% | 0% |
| 2025Q4 | 0.75% | 0% |
| 2025Q3 | 2.20% | 0% |
| 2025Q2 | 0.61% | 0% |
DXCM
Price: $89.75
52 week price:
Earnings Per Share: 2.53 USD
P/E Ratio: 32.67
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 3.0 million
Ebitda: 6.3 millionMarket Capitalization: 31.2 billion